title: The patentability of human embryonic stem cells in Europe.
abstract: Applicants in Europe are left with few options for the patent protection of hES cell-related technology.
authors.affiliation: University of Nottingham, School of Law, Nottingham NG7 2RD, UK.
authors.forename: Gerard
authors.initials: G
authors.lastname: Porter
authors.forename: Chris
authors.initials: C
authors.lastname: Denning
authors.forename: Aurora
authors.initials: A
authors.lastname: Plomer
authors.forename: John
authors.initials: J
authors.lastname: Sinden
authors.forename: Paul
authors.initials: P
authors.lastname: Torremans
mesh_terms: D005060:Europe; D005062:European Union / Q000458:organization & administration*; D033161:Government Regulation; D006801:Humans; D010067:Ownership / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000706:statistics & numerical data*; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence*